[Skip to Content]
Atrial Fibrillation

Catheter Ablation vs Drug Therapy for Patients With Atrial Fibrillation: The CABANA Trial

JAMA
Published Online: March 15, 2019 Video 5 min 57 sec

Two reports in JAMA detail findings from the CABANA trial, a randomized, open-label trial comparing the effects of drug therapy vs cardiac catheter ablation on a composite outcome of death, disabling stroke, serious bleeding, or cardiac arrest in patients with symptomatic atrial fibrillation. In this video, JAMA Deputy Editor Gregory Curfman, MD, describes the study and the clinical implications of the results.

Our websites may be periodically unavailable between 12:00am CT March 25, 2023 and 4:00pm CT March 26, 2023 for regularly scheduled maintenance.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Related Articles

  1. Highlights for March 19, 2019

  2. Catheter Ablation vs Antiarrhythmic Medication and Quality of Life in Atrial Fibrillation

  3. Catheter Ablation for Atrial Fibrillation

  4. Effect of Catheter Ablation vs Medical Therapy on Quality of Life in Patients With Atrial Fibrillation

  5. Effect of Catheter Ablation vs Antiarrhythmic Drugs on Mortality, Stroke, Bleeding, and Cardiac Arrest in AF

  6. Highlights for April 2, 2019

See More

See More About

Atrial Fibrillation Cardiology Cerebrovascular Disease Heart Failure Neurology Stroke Cerebrovascular Infarction Rhythm Disorders
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue